Clinical Trial Update: Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia [NA]

View source ↗

Summary

A completed clinical trial comparing Apidra (insulin glulisine) to Humalog (insulin lispro) for reducing post-prandial hyperglycemia in Type 1 diabetes; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)
• Humalog (insulin lispro)

Snippet

Sponsor: University of Florida | Conditions: Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2013-09-13